目前,自身免疫性甲状腺的发病率有增加趋势,它的治疗不外乎使用甲状腺素、强的松、左旋咪唑等。至于免疫调节疗法的应用,迄今还未正式拟定。自身免疫性和亚急性甲状腺炎均显示T细胞系统的免疫缺陷,T细胞亚群的正常比例失调和功能活性障碍。 作者对72例(男5,女67)自身免疫性(53例)和亚急性(19例)甲状腺炎患者的T细胞免疫状态进行了调查,并采用免疫调节疗法进行治疗,患者年龄为17～69岁。以60名健康人作为对照组。全部患者均根据临床资料、放射性同位素~(131)I检查、血 Currently, the incidence of autoimmune thyroid has an increasing trend, its treatment is nothing more than the use of thyroxine, prednisone, levamisole and so on. As for the application of immunomodulatory therapy, so far has not been formally drafted. Both autoimmune and subacute thyroiditis show immunodeficiency in the T cell system, normal proportion of T cell subsets, and dysfunctional activity. The authors investigated the T-cell immune status in 72 patients (male 5, female 67) with autoimmune (53) and subacute (19) thyroiditis patients treated with immunomodulatory therapy, aged 17-17 years, 69 years old. 60 healthy people as a control group. All patients were based on clinical data, radioisotope ~ (131) I check blood